medicare and glp-1 covers GLP-1s for $50/month starting July 2026 Medicare Expands GLP-1 Medication Access

Using alcohol, weed, or other substances for pain relief creates a self-perpetuating loop: short-lived relief reinforces repeated use, while underlying symptom generators persist

Due to legal restrictions however, over the last century, there are significant gaps in our understanding of how cannabis functions in the body, including how various inhaled products affect the pulmonary immune system

As of June 2026, 5-Amino-1MQ has no FDA-approved use

This evidence cautions against short-term use of weight management medications, emphasises the need for further research into cost effective strategies for long-term weight control, and reinforces the importance of primary prevention. In response, Dr Trevor Steward, a senior research fellow in the School of Psychological Sciences at the University of Melbourne, said the analysis confirms what many doctors have experienced in the real world, that weight often returns after patients stop their medications